Discontinued — last reported Q4 '25
CapEx at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: Lexicon Pharmaceuticals’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's capex?
- Lexicon Pharmaceuticals (LXRX) reported capex of $0 in Q4 2025.
- How has Lexicon Pharmaceuticals's capex changed year-over-year?
- Lexicon Pharmaceuticals's capex decreased by 100.0% year-over-year, from $474K to $0.
- What is the long-term trend for Lexicon Pharmaceuticals's capex?
- Over 3 years (2021 to 2024), Lexicon Pharmaceuticals's capex has grown at a -5.5% compound annual growth rate (CAGR), from $1.22M to $1.03M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.